Zoetis Inc. - ZTS (NYSE)

0.29 (0.38%)
Quotes delayed 15 mins. Currently January 21, 2018 11:30:25 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Zoetis Inc. engages in the discovery, development and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.

Key Financials

Day Range:76.22 - 76.91
52 Week Range:52.00 - 77.03
Market Cap:37.34B
P/E Ratio:40.30
Div Yield:0.66
Previous close
No Chart Available
Purchase ZTS in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of ZTS not only as a single stock, but also as part of a motif.
Professional Motifs with ZTS
Pet Passion
Pet Passion 25.7% 1 YR RTN In good times and bad, pet parents spoil their fuzzy friends.
View all professional motifs with ZTS
Community Motifs with ZTS
S&P 500 Profit Screen 17L
S&P 500 Profit Screen 17L 45.5% 1 YR RTN
Equus Paramutual
Equus Paramutual 60.2% 1 YR RTN
Fortress Stocks
Fortress Stocks 30.1% 1 YR RTN
View all community motifs with ZTS
What Others Think About ZTS
Gabriel Wilson
As Zoetis $ZTS Valuation Rose, Gareth Morgan Investments Limited Partnership Decreased Its Holding ...
Week Herald
Zoetis $ZTS Rating Reiterated by Piper Jaffray Companies weekherald.com/?p=1140150
Transcript Daily
Zoetis $ZTS Rating Reiterated by Piper Jaffray Companies zpr.io/nsAQk
Daily Political
Zoetis Inc $ZTS Receives Average Rating of “Buy” from Analysts dailypolitical.com/?p=1713760
US Banking News
Zoetis Inc $ZTS Receives Average Recommendation of “Buy” from Analysts americanbankingnews.com/?p=5640048 #stocks
Week Herald
Zoetis Inc $ZTS Receives Average Recommendation of “Buy” from Analysts weekherald.com/?p=1139779
James Sikes
Zoetis $ZTS Valuation Rose While Valicenti Advisory Services Decreased Position bzweekly.com/2018/01/20/zoe…
Marie Smith
10-15 Associates Has Decreased Its Zoetis $ZTS Stake by $1.31 Million heraldks.com/10-15-associat…
Related Companies Within The Drugs - Generic Sector
Allergan plc - 181.33
Mylan N.V. - 46.73